99 related articles for article (PubMed ID: 15564292)
41. Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis.
Kwon Y; Magnuson BA
Scand J Gastroenterol; 2007 Jan; 42(1):72-80. PubMed ID: 17190766
[TBL] [Abstract][Full Text] [Related]
42. A novel rasH2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies.
Miyamoto S; Yasui Y; Kim M; Sugie S; Murakami A; Ishigamori-Suzuki R; Tanaka T
Carcinogenesis; 2008 Feb; 29(2):418-26. PubMed ID: 18174262
[TBL] [Abstract][Full Text] [Related]
43. Prosurvival and antiapoptotic effects of PGE2 in radiation injury are mediated by EP2 receptor in intestine.
Houchen CW; Sturmoski MA; Anant S; Breyer RM; Stenson WF
Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G490-8. PubMed ID: 12431904
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice.
Watanabe K; Kawamori T; Nakatsugi S; Ohta T; Ohuchida S; Yamamoto H; Maruyama T; Kondo K; Narumiya S; Sugimura T; Wakabayashi K
Cancer Lett; 2000 Aug; 156(1):57-61. PubMed ID: 10840160
[TBL] [Abstract][Full Text] [Related]
45. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.
Hu Y; Le Leu RK; Young GP
Int J Cancer; 2005 Jul; 115(4):561-7. PubMed ID: 15700305
[TBL] [Abstract][Full Text] [Related]
46. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis.
Takagi T; Nakano Y; Takekoshi S; Inagami T; Tamura M
Carcinogenesis; 2002 Jul; 23(7):1235-41. PubMed ID: 12117783
[TBL] [Abstract][Full Text] [Related]
47. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.
Harman FS; Nicol CJ; Marin HE; Ward JM; Gonzalez FJ; Peters JM
Nat Med; 2004 May; 10(5):481-3. PubMed ID: 15048110
[TBL] [Abstract][Full Text] [Related]
48. T cell deficiency leads to liver carcinogenesis in azoxymethane-treated rats.
Wu B; Ootani A; Iwakiri R; Sakata Y; Fujise T; Amemori S; Yokoyama F; Tsunada S; Toda S; Fujimoto K
Exp Biol Med (Maywood); 2006 Jan; 231(1):91-8. PubMed ID: 16380649
[TBL] [Abstract][Full Text] [Related]
49. Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma.
Mohammed A; Janakiram NB; Madka V; Zhang Y; Singh A; Biddick L; Li Q; Lightfoot S; Steele VE; Lubet RA; Suen CS; Miller MS; Sei S; Rao CV
Cancer Prev Res (Phila); 2019 Nov; 12(11):751-762. PubMed ID: 31530543
[TBL] [Abstract][Full Text] [Related]
50. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice.
Kado S; Uchida K; Funabashi H; Iwata S; Nagata Y; Ando M; Onoue M; Matsuoka Y; Ohwaki M; Morotomi M
Cancer Res; 2001 Mar; 61(6):2395-8. PubMed ID: 11289103
[TBL] [Abstract][Full Text] [Related]
51. Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development.
Kawamori T; Uchiya N; Nakatsugi S; Watanabe K; Ohuchida S; Yamamoto H; Maruyama T; Kondo K; Sugimura T; Wakabayashi K
Carcinogenesis; 2001 Dec; 22(12):2001-4. PubMed ID: 11751431
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase C betaII and PKCiota/lambda: collaborating partners in colon cancer promotion and progression.
Murray NR; Weems J; Braun U; Leitges M; Fields AP
Cancer Res; 2009 Jan; 69(2):656-62. PubMed ID: 19147581
[TBL] [Abstract][Full Text] [Related]
53. Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice.
Olivo-Marston SE; Hursting SD; Lavigne J; Perkins SN; Maarouf RS; Yakar S; Harris CC
Mol Carcinog; 2009 Dec; 48(12):1071-6. PubMed ID: 19760669
[TBL] [Abstract][Full Text] [Related]
54. Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.
Peng Z; Heath J; Drachenberg C; Raufman JP; Xie G
BMC Cancer; 2013 Apr; 13():204. PubMed ID: 23617763
[TBL] [Abstract][Full Text] [Related]
55. Increased susceptibility of Sf1(+/-) mice to azoxymethane-induced colon tumorigenesis.
Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
Cancer Sci; 2007 Dec; 98(12):1862-7. PubMed ID: 17900258
[TBL] [Abstract][Full Text] [Related]
56. [Intestinal microflora and cancer prevention].
Morotomi M; Kado S
Gan To Kagaku Ryoho; 2003 Jun; 30(6):741-7. PubMed ID: 12852338
[TBL] [Abstract][Full Text] [Related]
57. Lactams as EP4 prostanoid receptor subtype selective agonists. Part 1: 2-Pyrrolidinones-stereochemical and lower side-chain optimization.
Elworthy TR; Kertesz DJ; Kim W; Roepel MG; Quattrocchio-Setti L; Smith DB; Tracy JL; Chow A; Li F; Brill ER; Lach LK; McGee D; Yang DS; Chiou SS
Bioorg Med Chem Lett; 2004 Apr; 14(7):1655-9. PubMed ID: 15026044
[TBL] [Abstract][Full Text] [Related]
58. Adiponectin is not effective against AOM-induced colon cancer but more evidence is required for its role in obesity-associated colon cancer: comment on the study by Ealey and Archer (2009).
Chen J; Huang XF
Int J Cancer; 2009 Nov; 125(10):2483; author reply 2484. PubMed ID: 19544561
[No Abstract] [Full Text] [Related]
59. Genetic ablation of M3 muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia.
Raufman JP; Samimi R; Shah N; Khurana S; Shant J; Drachenberg C; Xie G; Wess J; Cheng K
Cancer Res; 2008 May; 68(10):3573-8. PubMed ID: 18483237
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the role of protein kinase C isozymes in colon carcinogenesis using transgenic mouse models.
Fields AP; Murray NR; Gustafson WC
Methods Mol Biol; 2003; 233():539-53. PubMed ID: 12840533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]